Delivery Order SPE2DB20D9331-SPE2DB22FL0W1

Award Date 4/11/22
Potential Completion Date 4/12/22
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA) health facilities nationwide. The $11,089.08 firm fixed-price delivery order is issued under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency's Medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $74,135.50 firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, covers a comprehensive array of medications, including branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order with a ceiling value of $1,278.20. The contract was awarded by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities nationwide. The contract is part of a larger indefinite...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a variety of pharmaceutical items, including injectable medications, tablets, creams, and specialty drugs, to support the medical supply needs of U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,368.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program,...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) to support the medical needs of the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $1,573.20 firm fixed-price delivery order, which is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA, covers a comprehensive array of items...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract has a ceiling value of $1,547.40 and is a firm fixed-price delivery order with no set-aside designation. The award is part of a larger indefinite delivery contract (IDC) held by DMS...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The $1,278.20 firm fixed-price delivery order, with an ultimate completion date of July 25, 2024, is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of various pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $18,568.80 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, which runs through December 31, 2025....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, valued up to $1,892.90, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $12,934.05. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group specializes in supplying a wide range of branded and generic prescription drugs,...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB22FL0W1
    Delivery Order

This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, involves the supply of a range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The award, valued at $1,571.50, is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive array of pharmaceutical items to meet the recurring medical supply needs of military health facilities worldwide. The products supplied by DMS Pharmaceutical Group include both common and specialized medications, such as flumazenil injections, prednisone tablets, and oncology drugs. This contract does not have a set-aside designation and leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical prime vendor programs supporting military medical facilities globally.

Generated 1/9/25, 9:14 AM